TMCnet News
OvaScience Names Jeffrey Young as CFO [Professional Services Close - Up](Professional Services Close - Up Via Acquire Media NewsEdge) OvaScienceSM reported the appointment of Jeffrey Young to Chief Financial Officer. According to a release from the company, Young joins OvaScience from Transmedics, where he served as Chief Financial Officer and Treasurer. "We are pleased to welcome Jeff to the OvaScience team. Jeff's experience in international finance and global operations, including the establishment of international subsidiaries and ex-U.S. revenue and tax reporting requirements, will be important to OvaScience as we expand the availability of our AUGMENT treatment and launch the OvaPrime treatment internationally next year," said Michelle Dipp, M.D., Ph.D., Chief Executive Officer at OvaScience. Prior to serving as CFO of Transmedics, Young was CFO and Treasurer at Lantheus Medical Imaging. While at Lantheus, an international corporation, he was responsible for multiple functions, including finance, accounting, customer service, tax and treasury. He also assisted in raising $400 million in a registered notes offering. Before Lantheus, Young served as Chief Accounting Officer, Vice President of Finance and Treasurer at Critical Therapeutics, and managed the company's transition during its acquisition by Cornerstone BioPharma. ((Comments on this story may be sent to [email protected])) (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. [ Back To TMCnet.com's Homepage ] |